{"id":"https://openalex.org/W2980310295","doi":"https://doi.org/10.1182/blood.v112.11.921.921","title":"Development of a Prognostic Scoring System for Secondary Acute Myeloid Leukemia (sAML) Arising from Myelodysplastic Syndromes (MDS), Myeloproliferative Disorders (MPD), or Therapy-Related AML (t-AML).","display_name":"Development of a Prognostic Scoring System for Secondary Acute Myeloid Leukemia (sAML) Arising from Myelodysplastic Syndromes (MDS), Myeloproliferative Disorders (MPD), or Therapy-Related AML (t-AML).","publication_year":2008,"publication_date":"2008-11-16","ids":{"openalex":"https://openalex.org/W2980310295","doi":"https://doi.org/10.1182/blood.v112.11.921.921","mag":"2980310295"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v112.11.921.921","doi":"https://doi.org/10.1182/blood.v112.11.921.921","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v112.11.921.921","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051485142","display_name":"Sanjay Ram Mohan","orcid":"https://orcid.org/0000-0002-6715-6697","observed_orcids":["https://orcid.org/0000-0002-6715-6697"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sanjay R. Mohan","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111957341","display_name":"Paul J. Elson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Elson","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101636838","display_name":"Cristina P. Rodriguez","orcid":"https://orcid.org/0000-0002-9202-4813","observed_orcids":["https://orcid.org/0000-0002-9202-4813"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Cristina Rodriguez","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077110117","display_name":"Rachid Baz","orcid":"https://orcid.org/0000-0003-4538-4733","observed_orcids":["https://orcid.org/0000-0003-4538-4733"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rachid Baz","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112129467","display_name":"Matt E Kalaycio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Matt Kalaycio","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011655907","display_name":"Ronald M. Sobecks","orcid":"https://orcid.org/0000-0003-1608-3261","observed_orcids":["https://orcid.org/0000-0003-1608-3261"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ronald Sobecks","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082944296","display_name":"Anjali S. Advani","orcid":"https://orcid.org/0000-0003-0015-5902","observed_orcids":["https://orcid.org/0000-0003-0015-5902"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anjali Advani","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016679262","display_name":"Ed Copelan","orcid":"https://orcid.org/0000-0002-2784-2393","observed_orcids":["https://orcid.org/0000-0002-2784-2393"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ed Copelan","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064140300","display_name":"Lukasz P. Gondek","orcid":"https://orcid.org/0000-0002-1551-3496","observed_orcids":["https://orcid.org/0000-0002-1551-3496"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Lukasz P. Gondek","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085974329","display_name":"Jaroslaw Pawel Maciejewski","orcid":"https://orcid.org/0000-0002-6837-4346","observed_orcids":["https://orcid.org/0000-0002-6837-4346"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaroslaw P. Maciejewski","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055740968","display_name":"Mikkael Aaron Sekeres","orcid":"https://orcid.org/0000-0003-2009-6524","observed_orcids":["https://orcid.org/0000-0003-2009-6524"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mikkael A. Sekeres","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5011655907","https://openalex.org/A5016679262","https://openalex.org/A5051485142","https://openalex.org/A5064140300","https://openalex.org/A5077110117","https://openalex.org/A5101636838","https://openalex.org/A5112129467"],"corresponding_institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I3019308854"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.4312,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.70644181,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"112","issue":"11","first_page":"921","last_page":"921"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14078","display_name":"Multiple and Secondary Primary Cancers","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/secondary-acute-myeloid-leukemia","display_name":"secondary acute myeloid leukemia","score":0.996999979019165},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9480000138282776},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.9869999885559082},{"id":"https://openalex.org/keywords/therapy-related-acute-myeloid-leukemia","display_name":"therapy-related acute myeloid leukemia","score":0.8939999938011169},{"id":"https://openalex.org/keywords/prognostic-score","display_name":"prognostic score","score":0.9940000176429749},{"id":"https://openalex.org/keywords/induction-chemotherapy","display_name":"induction chemotherapy","score":0.6320000290870667},{"id":"https://openalex.org/keywords/cytarabine","display_name":"cytarabine","score":0.859000027179718},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.6660000085830688},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cytogenetic-risk","display_name":"cytogenetic risk","score":0.8790000081062317},{"id":"https://openalex.org/keywords/risk-stratification","display_name":"risk stratification","score":0.6069999933242798},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.5210000276565552}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7840704917907715},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7112709283828735},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.6331617832183838},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5733509063720703},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.572029709815979},{"id":"https://openalex.org/C2780240888","wikidata":"https://www.wikidata.org/wiki/Q6052586","display_name":"International Prognostic Scoring System","level":4,"score":0.546663224697113},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.5144210457801819},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.45347410440444946},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.44960904121398926},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3998766541481018},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.28058290481567383}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v112.11.921.921","doi":"https://doi.org/10.1182/blood.v112.11.921.921","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v112.11.921.921","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2556789334","https://openalex.org/W2536842264","https://openalex.org/W2580956723","https://openalex.org/W2088511291","https://openalex.org/W2244637987","https://openalex.org/W4386277476","https://openalex.org/W4381925250","https://openalex.org/W2065680405","https://openalex.org/W4385702320","https://openalex.org/W4292830471"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Patients":[2,506],"(pts)":[3],"with":[4,62,79,175,197,231,309,355,391,423,458,507,560,594],"sAML":[5,17,76,554,588],"are":[6],"evaluated":[7],"together":[8],"in":[9,44,115,276,281,285,290],"large":[10],"AML":[11,66,105,168,191,205,232,239,302,310,318,335,356,396,443,465,567],"trials":[12],"regardless":[13],"of":[14,59,140,201,242,414,447,483,500,534,576],"whether":[15],"their":[16],"arises":[18],"from":[19,23,50,146,170,207,234,246,259,311,319,336,357,361,397,402,417,420,437,466,470,568,571,597],"antecedent":[20,215,260],"MDS":[21,171,235,312,358,398,467,569],"vs.":[22,25,245,264,314,332,395,514,537],"MPD":[24,247,320,337,362,403,471],"t-AML.":[26,211],"Prognostic":[27],"factors":[28,87],"and":[29,36,72,104,112,122,164,221,226,250,266,288,293,321,338,349,377,486,544,583],"outcomes":[30],"may":[31],"differ":[32,380],"among":[33,296,381],"these":[34],"subgroups,":[35],"a":[37,56,256,412,497,531,563],"prognostic":[38,86,129,142,453,522,589],"scoring":[39,130,523,590],"system":[40,131,524,591],"would":[41,48,434],"be":[42],"helpful":[43],"determining":[45],"which":[46],"patients":[47,549,555,593],"benefit":[49],"induction":[51,81,199,557,598],"chemotherapy.":[52,82,599],"Methods:":[53],"We":[54],"conducted":[55],"retrospective":[57],"review":[58],"all":[60],"pts":[61,77,192,278,308,354,390,415,528,542,559],"newly":[63],"diagnosed,":[64],"pathologically-confirmed":[65],"at":[67,94,238,301],"Cleveland":[68],"Clinic":[69],"between":[70],"1997":[71],"2007":[73],"to":[74,464,478,493],"identify":[75],"treated":[78,196],"cytarabine-based":[80],"Data":[83],"on":[84,137,411],"known":[85],"(age,":[88],"white":[89],"blood":[90],"cell":[91],"count":[92],"(WBC)":[93],"diagnosis,":[95],"cytogenetic":[96],"risk":[97,272],"groups":[98,297,382],"(as":[99],"defined":[100],"by":[101],"CALGB":[102],"8461),":[103],"etiology)":[106],"were":[107,126,178,195,228,236,274,294,328,480,580],"collected":[108],"as":[109,327],"baseline":[110],"characteristics":[111],"controlled":[113],"for":[114,132,154,159,167,307,317,324,334,340,353,389,455,540,547],"stepwise":[116],"multivariable":[117,148,440],"analyses.":[118],"Complete":[119],"response":[120],"(CR)":[121],"overall":[123,344,372],"survival":[124,596],"(OS)":[125],"analyzed.":[127],"A":[128],"OS":[133,385,462,487,513,533,565,579],"was":[134,304,347,350,375,386,450,496],"developed":[135],"based":[136],"the":[138,521],"number":[139],"poor":[141],"features":[143],"present,":[144],"derived":[145],"significant":[147,481,498],"factors.":[149],"Pts":[150,174,230,457],"received":[151],"1":[152,157,165,180,419],"point":[153,158,166,181],"adverse":[155,284],"cytogenetics,":[156,476,581],"having":[160],"1-10%":[161],"peripheral":[162,329,509,584],"blasts,":[163],"arising":[169,206,233],"or":[172,184,210,364,401,430,469,474,516,570,578],"MPD.":[173,572],"0":[176],"points":[177,186],"favorable,":[179],"intermediate,":[182],"2":[183],"more":[185],"unfavorable.":[187],"Results:":[188],"Of":[189],"584":[190],"identified,":[193],"361":[194],"remission":[198],"therapy,":[200],"whom":[202],"90":[203],"had":[204,214,224,460,511,530],"MDS,":[208,216,418],"MPD,":[209,220,421],"Thirty-nine":[212],"(43%)":[213],"21":[217],"(23%)":[218],"an":[219,451],"30":[222],"(33%)":[223],"t-AML,":[225,325,341],"47%":[227],"female.":[229],"older":[237],"diagnosis":[240,303],"(median":[241],"67":[243],"years)":[244,249,253,495],"(61":[248],"t-AML":[251,365,392,459,561],"(60":[252],"(p=.02)":[254],"but":[255,367,449,503],"shorter":[257],"time":[258],"diagnosis/event":[261],"(7":[262],"months,":[263,268,405],"47":[265],"37":[267],"respectively":[269],"(p<0.001)).":[270],"Cytogenetic":[271],"categories":[273],"favorable":[275,527],"9":[277],"(10%),":[279],"intermediate":[280,541],"38":[282],"(42%),":[283],"27":[286],"(30%),":[287],"unknown":[289],"16":[291],"(18%)":[292],"similar":[295],"(p=.28).":[298],"Median":[299,384],"WBC":[300],"also":[305],"lower":[306,352],"(3.7k/uL,":[313],"9.9":[315],"k/uL":[316,323],"8.9":[322],"p=.04),":[326],"blasts":[330,510,518],"(11%,":[331],"29%":[333],"23%":[339],"p=.01).":[342],"The":[343,371,587],"CR":[345,448,484,501,577],"rate":[346,374],"51%":[348],"qualitatively":[351],"(38%)":[359],"than":[360,566],"(62%)":[363],"(60%),":[366],"not":[368,379,426,504],"significantly":[369,387],"(p=0.11).":[370],"reinduction":[373],"21%":[376],"did":[378,425],"(p=.76).":[383],"longer":[388,564],"(15":[393],"months)":[394,400],"(8":[399],"(11":[404],"p=.02).":[406],"Available":[407],"SNP":[408],"karyotyping":[409],"data":[410],"subset":[413],"(6":[416],"4":[422,545],"t-AML)":[424],"reveal":[427],"any":[428],"shared":[429],"cryptic":[431],"lesions":[432],"that":[433],"distinguish":[435],"responders":[436],"non-responders.":[438],"In":[439],"analyses,":[441],"secondary":[442],"etiology":[444],"remained":[445],"non-predictive":[446],"independent":[452],"factor":[454],"OS.":[456,505],"improved":[461,595],"compared":[463,477],"(p=.01)":[468],"(p=.08).":[472],"Favorable-":[473],"intermediate-risk":[475],"adverse,":[479],"predictors":[482,575],"(p<.001)":[485],"(p<.001).":[488],"Age":[489],"<60":[490],"years":[491],"(compared":[492],"360":[494],"predictor":[499],"(p=.02),":[502],"1\u201310%":[508],"worse":[512],"0%":[515],">10%":[517],"(p=.01).":[519],"Using":[520],"described":[525],"above,":[526],"(n=16)":[529],"median":[532],"40":[535],"months":[536,539,546],"12":[538],"(n=33)":[543],"unfavorable":[548],"(n=27,":[550],"p<.001).":[551],"Conclusions:":[552],"Among":[553],"undergoing":[556],"chemotherapy,":[558],"have":[562],"Other":[573],"important":[574],"age,":[582],"blast":[585],"%.":[586],"distinguished":[592]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2019-10-18T00:00:00"}